Medifast, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 04, 2021 at 04:26 pm EDT
Share
Medifast, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was USD 394.189 million compared to USD 219.999 million a year ago. Operating income was USD 61.434 million compared to USD 28.099 million a year ago. Net income was USD 46.963 million compared to USD 21.935 million a year ago. Basic earnings per share from continuing operations was USD 4 compared to USD 1.86 a year ago. Diluted earnings per share from continuing operations was USD 3.96 compared to USD 1.86 a year ago. For the half year, sales was USD 734.858 million compared to USD 398.460 million a year ago. Operating income was USD 114.233 million compared to USD 51.632 million a year ago. Net income was USD 88.026 million compared to USD 40.412 million a year ago. Basic earnings per share from continuing operations was USD 7.48 compared to USD 3.43 a year ago. Diluted earnings per share from continuing operations was USD 7.42 compared to USD 3.42 a year ago.
Medifast, Inc. is a health and wellness company. The Company provides a habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a comprehensive approach to help them achieve lasting optimal health and wellbeing. OPTAVIA's lifestyle plans deliver clinically proven health benefits as well as evidence-based tools, including scientifically developed products and a framework for habit creation reinforced by independent coaches and community support. Through a collaboration with the virtual primary care provider LifeMD, Inc (LifeMD), OPTAVIA customers have access to board-certified affiliated clinicians and medications, such as GLP-1s, that support treatment plans for obesity and other health conditions. OPTAVIA Coaches introduce customers to a set of healthy habits, and offer OPTAVIA-branded products, including Fuelings as well as OPTAVIA ACTIVE, a line of essential amino acid supplements and protein powders. Its operations are conducted through its subsidiaries.